CJC-1295 + Ipamorelin Blend

CJC-1295 + Ipamorelin is a dual-peptide combination widely utilized in laboratory research for the study of growth hormone-releasing pathways, receptor signaling, and endocrine system modulation. This combination is commonly investigated for its interaction with growth hormone-releasing hormone (GHRH) receptors and ghrelin receptors, allowing researchers to examine synergistic signaling effects, pulsatile hormone release patterns, and downstream cellular communication processes in controlled experimental models.

In research environments, this peptide pairing is used to analyze mechanisms related to hormone regulation, cellular growth signaling, and metabolic pathway interactions. CJC-1295 is studied for its role in sustained receptor activation, while Ipamorelin is examined for its selective receptor targeting and controlled signaling response. Together, they provide a model for evaluating coordinated receptor activity and its influence on cellular adaptation, protein signaling cascades, and endocrine feedback systems. Their stability and complementary mechanisms make them suitable for repeatable and structured experimental protocols.

Reconstitution (For Research Reference Only):
Add 2mL of bacteriostatic water to achieve a concentration of 10mg/mL. At this concentration, each 0.1mL (10 units on a standard insulin syringe) corresponds to 1mg of compound. This information is provided strictly for laboratory research standardization and measurement purposes.

This product is supplied in lyophilized (freeze-dried) form within a sealed vial to ensure stability and precision in handling. It is intended exclusively for laboratory research, analytical, and educational purposes and is not approved for—and must not be used for—human or animal consumption.